290 related articles for article (PubMed ID: 17961597)
21. Mitochondria and oxidative damage in amyotrophic lateral sclerosis.
Beal MF
Funct Neurol; 2001; 16(4 Suppl):161-9. PubMed ID: 11996512
[No Abstract] [Full Text] [Related]
22. Aging, energy, and oxidative stress in neurodegenerative diseases.
Beal MF
Ann Neurol; 1995 Sep; 38(3):357-66. PubMed ID: 7668820
[TBL] [Abstract][Full Text] [Related]
23. Altered neuronal activities in the motor cortex with impaired motor performance in adult rats observed after infusion of cerebrospinal fluid from amyotrophic lateral sclerosis patients.
Sankaranarayani R; Nalini A; Rao Laxmi T; Raju TR
Behav Brain Res; 2010 Jan; 206(1):109-19. PubMed ID: 19747511
[TBL] [Abstract][Full Text] [Related]
24. Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man.
Echaniz-Laguna A; Zoll J; Ponsot E; N'guessan B; Tranchant C; Loeffler JP; Lampert E
Exp Neurol; 2006 Mar; 198(1):25-30. PubMed ID: 16126198
[TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease.
Ryberg H; Söderling AS; Davidsson P; Blennow K; Caidahl K; Persson LI
Neurochem Int; 2004 Jul; 45(1):57-62. PubMed ID: 15082222
[TBL] [Abstract][Full Text] [Related]
26. Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis?
Mancuso M; Conforti FL; Rocchi A; Tessitore A; Muglia M; Tedeschi G; Panza D; Monsurrò M; Sola P; Mandrioli J; Choub A; DelCorona A; Manca ML; Mazzei R; Sprovieri T; Filosto M; Salviati A; Valentino P; Bono F; Caracciolo M; Simone IL; La Bella V; Majorana G; Siciliano G; Murri L; Quattrone A
Neurosci Lett; 2004 Nov; 371(2-3):158-62. PubMed ID: 15519748
[TBL] [Abstract][Full Text] [Related]
27. Cerebral magnetic resonance imaging pathology and cerebro-spinal fluid protein in sporadic amyotrophic lateral sclerosis (sALS).
Westarp ME; Schreiber H; Westarp MP; Westphal KP; Mauch E; Kornhuber HH
Clin Neuropathol; 1995; 14(4):228-32. PubMed ID: 8521627
[TBL] [Abstract][Full Text] [Related]
28. Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts.
Sala G; Trombin F; Mattavelli L; Beretta S; Tremolizzo L; Andreoni S; Calabrese E; Sanvito L; Ferrarese C
Neurodegener Dis; 2009; 6(1-2):9-15. PubMed ID: 18349520
[TBL] [Abstract][Full Text] [Related]
29. [Calcitonin level in cerebrospinal fluid of patients with amyotrophic lateral sclerosis].
Klimek A; Stepień H; Szulc-Kuberska J; Pisarek H
Pol Tyg Lek; 1992 Apr 6-13; 47(14-15):310-1. PubMed ID: 1437739
[TBL] [Abstract][Full Text] [Related]
30. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis.
Martin LJ
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1103-10. PubMed ID: 17146283
[TBL] [Abstract][Full Text] [Related]
31. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kaufmann E; Boehm BO; Süssmuth SD; Kientsch-Engel R; Sperfeld A; Ludolph AC; Tumani H
Neurosci Lett; 2004 Nov; 371(2-3):226-9. PubMed ID: 15519762
[TBL] [Abstract][Full Text] [Related]
32. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS).
Zhang R; Gascon R; Miller RG; Gelinas DF; Mass J; Lancero M; Narvaez A; McGrath MS
J Neuroimmunol; 2006 Oct; 179(1-2):87-93. PubMed ID: 16857270
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
[TBL] [Abstract][Full Text] [Related]
34. Only transient increase of serum CoQ subset 10 during long-term CoQ10 therapy in mitochondrial ophthalmoplegia.
Hanisch F; Zierz S
Eur J Med Res; 2003 Nov; 8(11):485-91. PubMed ID: 14644702
[TBL] [Abstract][Full Text] [Related]
35. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
[TBL] [Abstract][Full Text] [Related]
36. Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients.
Sakata T; Furuya R; Shimazu T; Odamaki M; Ohkawa S; Kumagai H
Blood Purif; 2008; 26(4):371-8. PubMed ID: 18509244
[TBL] [Abstract][Full Text] [Related]
37. High aluminum deposition in the central nervous system of patients with amyotrophic lateral sclerosis from the Kii Peninsula, Japan: two case reports.
Yasui M; Yase Y; Ota K; Mukoyama M; Adachi K
Neurotoxicology; 1991; 12(2):277-83. PubMed ID: 1956586
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies--a comment.
Vielhaber S; Kornblum C; Heinze HJ; Elger CE; Kunz WS
Brain; 2005 Dec; 128(Pt 12):E38. PubMed ID: 16311266
[No Abstract] [Full Text] [Related]
39. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Dobosz B
Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
[TBL] [Abstract][Full Text] [Related]
40. Lactate stress testing in sporadic amyotrophic lateral sclerosis.
Finsterer J
Int J Neurosci; 2005 Apr; 115(4):583-91. PubMed ID: 15809220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
